Nicole Germino
Stock Analyst at Truist Securities
(0)
# 3962
Out of 5,240 analysts
24
Total ratings
27.27%
Success rate
-3.73%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Insmed | Reiterates: Strong Buy | 100 105 | 69.9 | 50.21% | 7 | Nov 1, 2024 | |
Perspective Therapeu... | Initiates Coverage On: Buy | 21 | 3.17 | 562.46% | 1 | Sep 25, 2024 | |
Y-mAbs Therapeutics | Initiates Coverage On: Buy | 21 | 6.58 | 219.15% | 1 | Jun 28, 2024 | |
Fusion Pharmaceutica... | Downgrades: Hold | 11 21 | n/a | n/a | 3 | Mar 20, 2024 | |
Sangamo Therapeutics | Downgrades: Hold | n/a | n/a | n/a | 4 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 13 13 | n/a | n/a | 3 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 132 24 | 14.93 | 60.75% | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Sep 3, 2021 |